Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis
dc.contributor.author | Wolf, Risa M. | |
dc.contributor.author | Noor, Nudrat | |
dc.contributor.author | Izquierdo, Roberto | |
dc.contributor.author | Jett, Destiny | |
dc.contributor.author | Rewers, Amanda | |
dc.contributor.author | Majidi, Shideh | |
dc.contributor.author | Sheanon, Nicole | |
dc.contributor.author | Breidbart, Emily | |
dc.contributor.author | Demeterco-Berggren, Carla | |
dc.contributor.author | Lee, Joyce M. | |
dc.contributor.author | Kamboj, Manmohan K. | |
dc.contributor.author | Ebekozien, Osagie | |
dc.date.accessioned | 2022-06-01T20:28:46Z | |
dc.date.available | 2023-07-01 16:28:44 | en |
dc.date.available | 2022-06-01T20:28:46Z | |
dc.date.issued | 2022-06 | |
dc.identifier.citation | Wolf, Risa M.; Noor, Nudrat; Izquierdo, Roberto; Jett, Destiny; Rewers, Amanda; Majidi, Shideh; Sheanon, Nicole; Breidbart, Emily; Demeterco-Berggren, Carla ; Lee, Joyce M.; Kamboj, Manmohan K.; Ebekozien, Osagie (2022). "Increase in newly diagnosed type 1 diabetes in youth during the COVID- 19 pandemic in the United States: A multi- center analysis." Pediatric Diabetes 23(4): 433-438. | |
dc.identifier.issn | 1399-543X | |
dc.identifier.issn | 1399-5448 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/172806 | |
dc.description.abstract | BackgroundAn increase in newly diagnosed type 1 diabetes (T1D) has been posited during the COVID-19 pandemic, but data are conflicting. We aimed to determine trends in newly diagnosed T1D and severity of presentation at diagnosis for pediatric and adolescent patients during COVID-19 (2020) as compared to the previous year (2019) in a multi-center analysis across the United States.MethodsThis retrospective study from seven centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) included data on new onset T1D diagnosis and proportion in DKA at diagnosis from January 1 to December 31, 2020, compared to the prior year. Chi-square tests were used to compare differences in patient characteristics during the pandemic period compared to the prior year.ResultsAcross seven sites, there were 1399 newly diagnosed T1D patients in 2020, compared to 1277 in 2019 (p = 0.007). A greater proportion of newly diagnosed patients presented in DKA in 2020 compared to 2019 (599/1399(42.8%) vs. 493/1277(38.6%), p = 0.02), with a higher proportion presenting with severe DKA (p = 0.01) as characterized by a pH <7.1 and/or bicarbonate of <5 mmol/L. Monthly data trends demonstrated a higher number of new T1D diagnoses over the spring and summer months (March to September) of 2020 compared to 2019 (p < 0.001).ConclusionsWe found an increase in newly diagnosed T1D and a greater proportion presenting in DKA at diagnosis during the COVID-19 pandemic compared to the prior year. Future longitudinal studies are needed to confirm these findings with population level data and determine the long-term impact of COVID-19 on diabetes trends. | |
dc.publisher | John Wiley & Sons A/S | |
dc.subject.other | new onset | |
dc.subject.other | COVID-19 | |
dc.subject.other | diabetic ketoacidosis | |
dc.subject.other | newly diagnosed | |
dc.subject.other | type 1 diabetes | |
dc.title | Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Pediatrics | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172806/1/pedi13328.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172806/2/pedi13328_am.pdf | |
dc.identifier.doi | 10.1111/pedi.13328 | |
dc.identifier.source | Pediatric Diabetes | |
dc.identifier.citedreference | Cherubini V, Grimsmann JM, Åkesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia. 2020; 63: 1530 - 1541. | |
dc.identifier.citedreference | Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020; 4: e10 - e11. | |
dc.identifier.citedreference | Rosenberg Danziger C, Krause I, Scheuerman O, et al. Pediatrician, watch out for corona-phobia. Eur J Pediatr. 2021; 180: 201 - 206. | |
dc.identifier.citedreference | Beliard K, Ebekozien O, Demeterco-Berggren C, et al. Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: data from a multi-site surveillance registry. J Diabetes. 2021; 13: 270 - 272. | |
dc.identifier.citedreference | Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. Jama. 2020; 324: 801 - 804. | |
dc.identifier.citedreference | Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020; 43: 2870 - 2872. | |
dc.identifier.citedreference | Alonso GT, Ebekozien O, Gallagher MP, et al. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J Diabetes. 2021; 13: 681 - 687. | |
dc.identifier.citedreference | Ebekozien O, Agarwal S, Noor N, et al. Inequities in diabetic ketoacidosis among patients with type 1 diabetes and COVID-19: data from 52 US clinical centers. J Clin Endocrinol Metab. 2021; 106: e1755 - e1762. | |
dc.identifier.citedreference | Ebekozien OA, Noor N, Gallagher MP, Alonso GT. Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care. 2020; 43: e83 - e85. | |
dc.identifier.citedreference | Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020; 43: e170 - e171. | |
dc.identifier.citedreference | Marks BE, Khilnani A, Meyers A, et al. Increase in the diagnosis and severity of presentation of pediatric type 1 and type 2 diabetes during the COVID-19 pandemic. Horm Res Paediatr. 2021: 94 ( 7–8 ): 275 - 284. | |
dc.identifier.citedreference | Barrett CEKA, Alvarez P, et al. Risk for new diagnosed diabetes >30days after SARS-CoV-2 infection among persons ages <18years - United States, march 1, 2020 - June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022; 71: 59 - 65. | |
dc.identifier.citedreference | Kamrath C, Rosenbauer J, Tittel SR, et al. Frequency of autoantibody-negative type 1 diabetes in children, adolescents, and young adults during the first wave of the COVID-19 pandemic in Germany. Diabetes Care. 2021: 44 ( 7 ): 1540 – 1546. | |
dc.identifier.citedreference | Tittel SR, Rosenbauer J, Kamrath C, et al. Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care. 2020; 43: e172 - e173. | |
dc.identifier.citedreference | Alonso GT, Corathers S, Shah A, et al. Establishment of the T1D exchange quality improvement collaborative (T1DX-QI). Clin Diabetes. 2020; 38: 141 - 151. | |
dc.identifier.citedreference | Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D exchange clinic registry. J Clin Endocrinol Metab. 2012; 97: 4383 - 4389. | |
dc.identifier.citedreference | Prahalad P, Rioles N, Noor N, Rapaport R, Weinstock RS, Ebekozien O. T1D exchange quality improvement collaborative: accelerating change through benchmarking and improvement science for people with type 1 diabetes. J Diabetes. 2022; 14: 83 - 87. | |
dc.identifier.citedreference | Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19 ( suppl 27 ): 155 - 177. | |
dc.identifier.citedreference | Alonso GT, Coakley A, Pyle L, Manseau K, Thomas S, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado children, 2010-2017. Diabetes Care. 2020; 43: 117 - 121. | |
dc.identifier.citedreference | Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017; 376: 1419 - 1429. | |
dc.identifier.citedreference | Jensen ET, Stafford JM, Saydah S, et al. Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2021; 44: 1573 - 1578. | |
dc.identifier.citedreference | Duca LM, Reboussin BA, Pihoker C, et al. Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: the SEARCH for diabetes in youth study. Pediatr Diabetes. 2019; 20: 172 - 179. | |
dc.identifier.citedreference | Hartmann-Boyce J, Morris E, Goyder C, et al. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care. 2020; 43: 1695 - 1703. | |
dc.identifier.citedreference | Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. Jama. 2020; 323: 2466 - 2467. | |
dc.identifier.citedreference | Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia. 2019; 62: 408 - 417. | |
dc.identifier.citedreference | Kamrath C, Rosenbauer J, Eckert AJ, et al. Incidence of COVID-19 and risk of diabetic ketoacidosis in new-onset type 1 diabetes. Pediatrics. 2021; 148 ( 3 ): e2021050856. | |
dc.identifier.citedreference | Alidjinou EK, Sané F, Engelmann I, Geenen V, Hober D. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov Med. 2014; 18: 273 - 282. | |
dc.identifier.citedreference | Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 2008; 57: 2863 - 2871. | |
dc.identifier.citedreference | Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015; 64: 1682 - 1687. | |
dc.identifier.citedreference | Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011; 342: d35. | |
dc.identifier.citedreference | Olsen SJWA, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 1013 - 1019. | |
dc.identifier.citedreference | National norovirus and rotavirus bulletin week 51: data to week 49 (12 December 2021) Ref: UKHSA publication gateway number GOV-10858PDF, 312 KB, 12 pages. | |
dc.identifier.citedreference | Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8: 782 - 792. | |
dc.identifier.citedreference | Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020; 8: 813 - 822. | |
dc.identifier.citedreference | Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020; 383: 789 - 790. | |
dc.identifier.citedreference | Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010; 47: 193 - 199. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.